PRACTICAL ONCOLOGY JOURNAL ›› 2016, Vol. 30 ›› Issue (5): 396-399.doi: 10.11904/j.issn.1002-3070.2016.05.003

• Articles • Previous Articles     Next Articles

Effect of 5-aminolevulinic acid mediated photodynamic therapy in combination with recombinant human interferon alpha 2b ointment on basal cell carcinoma in elderly

ZHOU Junmin1, DAI Shaochun1, ZHOU Sen2   

  1. 1.Department of Dermatology,The Affiliated Tumor Hospital of Harbin Medical University,Harbin 150081,China;
    2.Heilongjiang Provincial Hospital
  • Received:2016-05-25 Online:2016-10-28 Published:2016-11-02

Abstract: Objective To evaluate the therapeutic effect of 5-aminolevulinic acid mediated photodynamic therapy(ALA-PDT)in combination with recombinant human interferon alpha 2b ointment on superficial basal cell carcinoma(BCC)in elderly.Methods A total of 143 elderly patients with superficial BCC was randomly divided into PDT group(n=72 cases)and the surgical group(n=71 cases).The patients in the two groups were given the ALA-PDT in combination with IFN-α2b and routine surgical treatment respectively.The efficacy after treatment was observed according to surgical wound area,lesion area,recurrence and security during 1 year follow-up.Results The Results displayed the complete remission rate of lesion in the PDT group was significantly higher than that in the surgical group(81.94% vs.57.75%,P<0.05)after treatment,and the total effective rate of BCC was also higher than that in the surgical group,but no significant difference was identified in the two groups(91.66% vs.81.73%,P> 0.05).During 1 year follow-up after treatment,the Results showed the rate of recurrence in the PDT group was significantly lower than that in the surgical group(9.72% vs.22.54%,P<0.05).Moreover,the mean wound area,the lesion area in the PDT group after treatment were also significantly smaller than that in the surgical group(P<0.05).Conclusion ALA-PDT in combination with IFN is an effective method with lower recurrence and minor trauma in the treatment of superficial basal cell carcinoma.

Key words: 5-Aminolevulinic acid, Photodynamic therapy, Interferon, Superficial basal cell carcinoma

CLC Number: